Evidence map›Paper›PMID 40994946›Full record

ReviewFrontiers in oncology2025

Natural products targeting ferroptosis in cancer: molecular mechanisms and applications.

Xin Ye, Xiaoli Ju

Abstract readReview
In one paragraph

Review in Frontiers in oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Xin YeDepartment of Pathology, Danyang Hospital of Traditional Chinese Medicine, Zhenjiang, Jiangsu, China.
Xiaoli JuDepartment of Pathology, School of Medicine, Jiangsu University, Zhenjiang, Jiangsu, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Ferroptosis is a novel class of programmed cell death that is mainly dependent on intracellular iron accumulation and lipid peroxidation. Ferroptosis is closely related to a variety of human diseases, especially different kinds of cancer. Several small molecule inducers have been developed to induce ferroptosis in tumor cells, some of which have been used in clinical studies. However, these chemical small molecules have toxic effects that limit its wide application. Natural products, however, have a natural advantage in cancer therapy due to their low toxicity and side effects. Some natural products have been found to inhibit tumor growth by inducing ferroptosis in tumor cells. In this review, we reviewed the molecular mechanism of ferroptosis and how natural products targeting ferroptosis signaling pathways affect tumor growth. We also analyzed the application of various natural products such as flavonoids, terpenoids, and alkaloids in inducing ferroptosis in tumor cells. This review will assist in the future discovery and study of more natural product inducers that can induce ferroptosis in tumor cells, and ultimately provide insights into identifying natural products that can be applied to clinical applications.

Indexed as

applicationscancerferroptosismolecular mechanismsnatural products

Identifiers

PMID40994946
PMCPMC12454074

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.